Filters

See more specimen types...
See more states

Other countries

Results: 1 to 20 of 136

Tests names and labsConditionsGenes, analytes, and microbesMethods

CentoCancer panel

Centogene AG - the Rare Disease Company
Germany
5231
  • C Sequence analysis of the entire coding region

Solid Tumor Panel

Centogene AG - the Rare Disease Company
Germany
4062
  • C Sequence analysis of the entire coding region

Cancer Hotspot Panel

Centogene AG - the Rare Disease Company
Germany
4688
  • E Sequence analysis of select exons

MarrowZoom

Johns Hopkins Genomics DNA Diagnostic Laboratory Johns Hopkins Hospital
United States
244149
  • C Sequence analysis of the entire coding region

Inherited Bone Marrow Failure Panel

PreventionGenetics
United States
230140
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

TumorNext®-HRD+BRCANext-Expanded™

Ambry Genetics
United States
7924
  • D Deletion/duplication analysis
  • M Methylation analysis
  • C Sequence analysis of the entire coding region

TumorNext®-Lynch+BRCANext-Expanded™

Ambry Genetics
United States
9526
  • D Deletion/duplication analysis
  • M Methylation analysis
  • C Sequence analysis of the entire coding region

BRCANext-Expanded™

Ambry Genetics
United States
3723
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

BRCANext™

Ambry Genetics
United States
3718
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Osteosarcoma, somatic, 259500 (Osteosarcoma) (CHEK2 gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Genetic Diagnosis and Research Centre
Turkey
11
  • C Sequence analysis of the entire coding region

Osteosarcoma, somatic, 259500 (Osteosarcoma) (RB1 gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Genetic Diagnosis and Research Centre
Turkey
11
  • C Sequence analysis of the entire coding region

Medulloblastoma Panel

PreventionGenetics
United States
219
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Wilms Tumor Panel

PreventionGenetics
United States
4828
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Bone Cancers

Aventus Biolabs
United States
230
  • E Sequence analysis of select exons

Aventus GenSeq

Aventus Biolabs
United States
66133
  • C Sequence analysis of the entire coding region

CancerNext® +RNAinsight®

Ambry Genetics
United States
7936
  • D Deletion/duplication analysis
  • R RNA analysis
  • C Sequence analysis of the entire coding region

CustomNext-Cancer® +RNAinsight®

Ambry Genetics
United States
14791
  • D Deletion/duplication analysis
  • R RNA analysis
  • C Sequence analysis of the entire coding region

MelanomaNext® +RNAinsight®

Ambry Genetics
United States
409
  • D Deletion/duplication analysis
  • R RNA analysis
  • C Sequence analysis of the entire coding region

BrainTumorNext® +RNAinsight®

Ambry Genetics
United States
7229
  • D Deletion/duplication analysis
  • R RNA analysis
  • C Sequence analysis of the entire coding region

ProstateNext® +RNAinsight®

Ambry Genetics
United States
4014
  • D Deletion/duplication analysis
  • R RNA analysis
  • C Sequence analysis of the entire coding region

Results: 1 to 20 of 136

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.

Support Center